|
WO2021021816A1
|
|
Calpain inhibitors and uses thereof for treating neurological disorders
|
|
CA3105069A1
|
|
Methods of treating liver fibrosis using calpain inhibitors
|
|
WO2020006177A1
|
|
Vascular adhesion protein-1 (vap-1) modulators and therapeutic uses thereof
|
|
WO2019217465A1
|
|
Calpain modulators and therapeutic uses thereof background
|
|
BR112020019325A2
|
|
METHOD OF TREATING FIBROTIC DISEASE
|
|
AU2019242387A1
|
|
Calpain modulators and therapeutic uses thereof
|
|
CA3067063A1
|
|
Calpain modulators and therapeutic uses thereof
|
|
PE20191153A1
|
|
CALPAINE MODULATORS AND THERAPEUTIC USES OF THE SAME
|
|
AU2017292646A1
|
|
Calpain modulators and therapeutic uses thereof
|
|
WO2017156071A1
|
|
Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
|
|
AU2017229591A1
|
|
Calpain modulators and methods of production and use thereof
|
